David W. Osborne, Chief Technical Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 15,000 shares at $30.00 ($450K) on 2020-09-29, disclosed to the SEC on 2020-10-01.
Open-market sale of $450k ARQT by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARQT | SELL | 2022-07-12 | $112K | — | Filing → |
| ARQT | SELL | 2022-04-21 | $45K | — | Filing → |
| ARQT | SELL | 2022-03-07 | $14K | — | Filing → |